The tumor-bearing BALB/c nude mice model was prepared through the subcutaneous injection of 0.1 mL HepG2 cell suspension (5 × 107 cells/mL) into the right sides of their backs. For the in vivo distribution, tumor-bearing mice were randomly assigned to two groups with three mice per group: ICG and MLPs. ICG and MLPs were administered in amounts of 200 μL through the tail vein. In vivo near-infrared imaging was taken using an IVIS Lumina XR Imaging System (Caliper Life Sciences, PerkinElmer, Inc.). To further monitor tumor accumulation, mice were anesthetized with 1.5% isoflurane at 1:2 O2/N2; the IVIS imaging system (excitation of 745 nm) was used to view the tumor accumulation profile. Mice were sacrificed after 24 h and the tumor, heart, liver, kidney, lung, and spleen were excised. These organs were also imaged at the aforementioned excitation wavelength.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.